Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen.

Boyle S, Kolin DL, Bieler JG, Schneck JP, Wiseman PW, Edidin M.

Biophys J. 2011 Dec 7;101(11):L57-9. doi: 10.1016/j.bpj.2011.10.028.

2.

A high fat diet containing saturated but not unsaturated fatty acids enhances T cell receptor clustering on the nanoscale.

Shaikh SR, Boyle S, Edidin M.

Prostaglandins Leukot Essent Fatty Acids. 2015 Sep;100:1-4. doi: 10.1016/j.plefa.2015.05.001. Epub 2015 May 29.

3.

The coreceptor CD4 is expressed in distinct nanoclusters and does not colocalize with T-cell receptor and active protein tyrosine kinase p56lck.

Roh KH, Lillemeier BF, Wang F, Davis MM.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1604-13. doi: 10.1073/pnas.1503532112. Epub 2015 Mar 17.

4.

Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.

Quah BJ, Wijesundara DK, Ranasinghe C, Parish CR.

J Immunol Methods. 2013 Jan 31;387(1-2):181-90. doi: 10.1016/j.jim.2012.10.013. Epub 2012 Oct 30.

PMID:
23123200
5.

Ig-specific T cell receptor-transgenic T cells are not deleted in the thymus and are functional in vivo.

Granucci F, Rescigno M, Marconi G, Foti M, Ricciardi-Castagnoli P.

J Exp Med. 1996 Jan 1;183(1):203-13.

6.

Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor.

Hamad AR, O'Herrin SM, Lebowitz MS, Srikrishnan A, Bieler J, Schneck J, Pardoll D.

J Exp Med. 1998 Nov 2;188(9):1633-40.

7.

Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement.

Skrenta H, Yang Y, Pestka S, Fathman CG.

J Immunol. 2000 Apr 1;164(7):3506-11.

8.

Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.

Fife BT, Griffin MD, Abbas AK, Locksley RM, Bluestone JA.

J Clin Invest. 2006 Aug;116(8):2252-61.

9.
10.

The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo.

DiMolfetto L, Neal HA, Wu A, Reilly C, Lo D.

Cell Immunol. 1998 Jan 10;183(1):70-9.

PMID:
9578721
11.

A yeast surface display system for the discovery of ligands that trigger cell activation.

Cho BK, Kieke MC, Boder ET, Wittrup KD, Kranz DM.

J Immunol Methods. 1998 Nov 1;220(1-2):179-88.

PMID:
9839939
12.

Analysis of the individual role of the TCRzeta chain in transgenic mice after conditional activation with chemical inducers of dimerization.

Soldevila G, Castellanos C, Malissen M, Berg LJ.

Cell Immunol. 2001 Dec 15;214(2):123-38.

PMID:
12088411
13.

Live cell fluorescence imaging of T cell MEKK2: redistribution and activation in response to antigen stimulation of the T cell receptor.

Schaefer BC, Ware MF, Marrack P, Fanger GR, Kappler JW, Johnson GL, Monks CR.

Immunity. 1999 Oct;11(4):411-21. Erratum in: Immunity 2001 May;14(5):655-6.

15.

Collaboration of TCR-, CD4- and CD28-mediated signalling in antigen-specific MHC class II-restricted T-cells.

Gogolák P, Réthy B, Horváth A, Tóth GK, Cervenák L, László G, Rajnavölgyi E.

Immunol Lett. 1996 Dec;54(2-3):135-44.

PMID:
9052868
18.

The role of TCR engagement and activation-induced cell death in sepsis-induced T cell apoptosis.

Unsinger J, Herndon JM, Davis CG, Muenzer JT, Hotchkiss RS, Ferguson TA.

J Immunol. 2006 Dec 1;177(11):7968-73.

19.

Molecular motors involved in T cell receptor clusterings.

Krawczyk C, Penninger JM.

J Leukoc Biol. 2001 Mar;69(3):317-30. Review.

PMID:
11261777
20.

T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.

Haskins K.

J Autoimmun. 2004 Mar;22(2):107-9. Review. No abstract available.

PMID:
14987737

Supplemental Content

Support Center